HALOZYME PROVIDES 2022 FINANCIAL GUIDANCE AND OUTLOOK
Go back to HALOZYME PROVIDES 2022 FINANCIAL GUIDANCE AND OUTLOOK| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 71.64 +0.11 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $71.53 | 52 Week High | $18.39 | |||
| Open | $71.59 | 52 Week Low | $6.96 | |||
| Day High | $71.92 | P/E | N/A | |||
| Day Low | $70.80 | EPS | $-0.58 | |||
| Volume | 539,226 | |||||
